$42.26
0.01[0.02%]
At close: Apr 22
$42.26
0[0.00%]
After Hours: 4:01PM EDT
Taro Pharmaceutical Indus
(NYSE:TARO)Latest News for Taro Pharmaceutical Indus Stock (NYSE:TARO)
Taro Pharmaceutical Indus Stock (NYSE: TARO)
Categories: All
Tuesday, January 30, 2024
Thursday, January 25, 2024
Wednesday, January 24, 2024
Thursday, January 18, 2024
Wednesday, January 17, 2024
Thursday, October 26, 2023
Wednesday, October 25, 2023
Thursday, July 27, 2023
Wednesday, July 26, 2023
Tuesday, May 30, 2023
- Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - May 30, 2023, 1:27PM
- Taro Pharmaceuticals shares are trading higher after Sun Pharmaceutical informed the Board that it was considering to make a proposal to acquire all of the outstanding ordinary shares of the company.Benzinga Newsdesk - May 30, 2023, 11:41AM
Monday, March 27, 2023
Wednesday, March 15, 2023
Wednesday, January 25, 2023
Tuesday, January 24, 2023
Monday, January 23, 2023
Thursday, October 27, 2022
Wednesday, October 26, 2022
Monday, September 19, 2022
Monday, August 15, 2022
Wednesday, July 27, 2022
- Taro Pharmaceutical Indus: Q1 Earnings InsightsBenzinga Insights - Jul 27, 2022, 6:08PM
- Taro Pharmaceutical Indus Q1 EPS $0.37 Down From $1.09 YoY, Sales $156.66M Up From $147.11M YoYBenzinga Newsdesk - Jul 27, 2022, 5:30PM
- Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia TherapyVandana Singh - Jul 27, 2022, 9:28AM
- Earnings Scheduled For July 27, 2022Benzinga Insights - Jul 27, 2022, 4:43AM
Thursday, May 26, 2022
Wednesday, May 25, 2022
Sunday, May 22, 2022
Friday, April 29, 2022
Monday, January 31, 2022
Friday, January 28, 2022
Thursday, January 27, 2022
- Taro Pharmaceutical Indus Q3 EPS $0.70 Down From $0.86 YoY, Sales $139.00M Miss $142.22M EstimateBenzinga Newsdesk - Jan 27, 2022, 5:01PM
- The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster StudyShanthi Rexaline - Jan 27, 2022, 7:57AM
- Earnings Scheduled For January 27, 2022Benzinga Insights - Jan 27, 2022, 4:37AM
Tuesday, January 18, 2022
Thursday, December 02, 2021
Wednesday, December 01, 2021
Thursday, November 04, 2021
Thursday, October 28, 2021
- Taro Pharmaceutical Indus Q2 Adj. EPS $0.66 Down From $1.18 YoY, Sales $132.00M Down From $142.84M YoYBenzinga Newsdesk - Oct 28, 2021, 5:34PM
- The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer DrugShanthi Rexaline - Oct 28, 2021, 8:26AM